NASDAQ:NRSN | Cash Flow Statement | NeuroSense Therapeutics Ltd.

Complete source-backed cash-flow history.

Available history
2022-12-31 to 2025-12-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$11.13M-$7.67M$8,000.00-$8,000.00$4.43M
2024-12-31-$10.21M-$10.14M$3,000.00$1,000.00$10.91M
2023-12-31-$10.11M-$8.35M$29,000.00$3.47M$3.98M
2022-12-31-$10.49M-$7.62M$70,000.00-$3.59M$3.77M